Kathryn C. Zoon - 04 Jun 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
04 Jun 2024
Net transactions value
-$61,100
Form type
4
Filing time
06 Jun 2024, 16:16:20 UTC
Previous filing
31 May 2024
Next filing
12 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $61,100 -10,000 -16% $6.11 54,482 04 Jun 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.